Bayer's expanded therapies and strategic collaborations in India aim to drive pharmaceutical growth amidst regulatory challenges and pricing pressures.

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch of one of the ...

A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests ...

Female entrepreneurs in the fields of health and food security have the chance to receive significant support through the ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Growing profits and a recovery in its industry could propel the stock in 2025.

Ed Field discovered his passion for building biotechnology innovation while working with an equity-backed biopharma start-up ...

Bayer AG (Leverkusen, Germany) announced a deal with Canada-based Smart Earth Camelina Corp., whereby Bayer has acquired ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

BEIJING - The gross domestic product (GDP) of the Chinese capital, Beijing, increased about 5.2 percent year-on-year in 2024, ...